Seasonal influenza causes significant burden to society annually. This includes burden of disease (morbidity, mortality, burden on health care capacity), as well as economic burden. Since vaccines are available to reduce risk of serious disease and death, countries have an important opportunity to mitigate the impact of influenzavirus.
However, few countries generate reliable national data on the burden of disease, or on the economic impact of seasonal influenza. For countries that want to develop policies on evidence of cost and effect of influenza prevention & control, national data on impact of influenza are a critical starting point.
This course has two tracks. Each track is fully based on one of the WHO manuals on influenza burden:
When you follow the course, you will be guided through all methodological and practical issues to implement a successful burden of disease study in your country. In addition to guiding you through the manuals, the course will present common problems that occur when using available health care data, and help you find solutions. The prerequisites of this course are basic knowledge of public health systems and familiarity with the introductory level knowledge and skills in epidemiology.
You may decide to only follow the first track, on Disease Burden. If you want to also follow the second track, on Estimating the Economic Impact, then we strongly recommend to do so after completing the first track.Please be aware that certificates of achievement and of participation will only be available for participants that complete both tracks.
If you would like to enroll for this course, there are no formal prerequisites or limitations. The course is free and open for everyone. Just register for an account on OpenWHO and go for the course!Enroll me now
A record of achievement is issued to those who have earned more than 75% of the maximum number of points for the sum of all graded assignments. A confirmation of participation is issued to those who have completed at least 80% of the course material.